Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy-Reference-Cited by-同舟云学术

Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy

Published:2022-06 Issue:6 Volume:81 Page:570-573
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Carlo Maria I.,Attalla Kyrollis,Mazaheri Yousef,Gupta Sounak,Yildirim Onur,Murray Samuel J.,Coskey Devyn T.,Kotecha Ritesh,Lee Chung-Han,Feldman Darren R.,Russo Paul,Patil Sujata,Motzer Robert J.,Coleman Jonathan A.,Durack Jeremy C.,Chen Ying-Bei,Akin Oguz,Ari Hakimi A.,Voss Martin H.

Publisher

Elsevier BV

Subject

Urology

Reference10 articles.

1. The impact of histological subtype on the incidence, timing, and patterns of recurrence in patients with renal cell carcinoma after surgery—results from RECUR Consortium;Abu-Ghanem;Eur Urol Oncol,2021

2. Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma;Choueiri;N Engl J Med,2021

3. Preoperative nomogram predicting 12-year probability of metastatic renal cancer—evaluation in a contemporary cohort;Mano;Urol Oncol,2020

4. Textural features for image classification;Haralick;IEEE Trans Syst Man Cybern,1973

5. Texture classification using Gabor wavelets based rotation invariant features;Arivazhagan;Pattern Recognit Lett,2006

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspectives on Neoadjuvant Clinical Trial Participation for Patients with Kidney Cancer: A Survey-Based Examination;Kidney Cancer;2024-08-19

2. Perioperative immunotherapy in renal cell carcinoma;The Lancet Oncology;2024-08

3. A Narrative Review on Systemic Therapy for Renal Cell Carcinoma in the Perioperative Setting;Journal of Urologic Oncology;2024-07-31

4. Prediction of clear cell renal cell carcinoma ≤ 4cm: visual assessment of ultrasound characteristics versus ultrasonographic radiomics analysis;Frontiers in Oncology;2024-07-23

5. Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial;Journal for ImmunoTherapy of Cancer;2024-06